811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Park National Corporation reported first-quarter 2025 net income of $42.2 million, up 19.8% from $35.2 million a year earlier, with diluted earnings per share of $2.60 versus $2.17. The company also declared a quarterly cash dividend of $1.07 per common share, payable June 10, 2025, to shareholders of record as of May 16, 2025.
Diluted EPS was $2.60, compared with $2.17 in Q1 2024.
Net interest income rose 9.2% to $104.4 million from $95.6 million a year earlier.
Other income fell 17.1% from the fourth quarter of 2024, to $25.7 million.
Quarterly dividend of $1.07 per share is payable June 10, 2025, to holders of record May 16, 2025.
Tompkins Financial reported first-quarter 2025 diluted earnings per share of $1.37, up 16.1% from $1.18 a year earlier, and net income of $19.7 million, up 16.6% from $16.9 million. The increase was mainly driven by higher net interest income, partly offset by a higher provision for credit losses. The board also declared a $0.62 per share dividend, payable May 16, 2025.
Diluted EPS of $1.37 for Q1 2025, versus $1.18 in Q1 2024 and unchanged from Q4 2024
Net income of $19.7 million, up 16.6% from $16.9 million a year earlier
Net interest margin of 2.98%, up from 2.73% in Q1 2024; provision for credit losses was $5.3 million versus $854,000
Dividend of $0.62 per share declared April 24, 2025, payable May 16, 2025, to holders of record on May 9, 2025
HCA Healthcare reported first-quarter 2025 revenue of $18.321 billion, up from $17.339 billion a year earlier, and net income attributable to the company of $1.610 billion, or $6.45 per diluted share, versus $5.93 in the first quarter of 2024. The prior-year quarter included $0.57 per share in facility sale gains, so the earnings comparison is stronger on an adjusted basis. The company reaffirmed its 2025 guidance and declared a $0.72 quarterly dividend.
Revenue $18.321 billion in Q1 2025 vs. $17.339 billion in Q1 2024
Diluted EPS $6.45 vs. $5.93; Q1 2024 included $0.57 per share from facility sale gains
Same facility admissions up 2.6 percent; operating cash flow $1.651 billion vs. $2.469 billion
2025 diluted EPS guidance of $24.05 to $25.85 reaffirmed; $0.72 dividend payable June 30, 2025
Sensient reported first-quarter 2025 revenue up 2.0% to $392.3 million and reported earnings per share up 11.0% to 81 cents, with operating income up 8.3% to $53.5 million. The company raised its full-year 2025 GAAP diluted EPS guidance to between $3.13 and $3.23 from $3.05 to $3.15, and reaffirmed its other 2025 guidance metrics.
Q1 2025 revenue $392.3 million, up 2.0% reported and 4.1% in local currency
2025 GAAP diluted EPS guidance raised to $3.13-$3.23 from $3.05-$3.15; includes about 15 cents of Portfolio Optimization Plan costs
Net debt to credit adjusted EBITDA was 2.5x at March 31, 2025, versus 2.6x a year earlier; operating cash flow was negative $9.0 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.